Independent studies have shown that the CXCL10/CXCR3 axis plays an extremely important immunomodulatory role in ischemic heart disease, myocarditis, leukoplakia, nonischemic heart failure, and KD, thus modulation of this axis is a potential immunotherapy target for these diseases.40 The gene discussed is CXCL10; the disease is Oral leukoplakia.